Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02426125 |
|---|---|
| Brief Title: | A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer (RANGE) |
| First Submitted : | April 21, 2015 |
| First Submitted that Met QC Criteria : | April 21, 2015 |
| First Posted : | April 24, 2015 (Estimate) |
| Results First Submitted : | January 25, 2019 |
| Results First Submitted that Met QC Criteria : | March 6, 2019 |
| Results First Posted : | March 8, 2019 |
| Certification/Extension First Submitted : | August 15, 2017 |
| Certification/Extension First Submitted that Met QC Criteria : | August 15, 2017 |
| Certification/Extension First Posted : | August 18, 2017 |
| Last Update Submitted that Met QC Criteria : | July 28, 2022 |
| Last Update Posted : | August 2, 2022 |